CARE Congress on Biosimilars/SEBs

About the CARE Congress on Biosimilars/SEBs:

This congress will be led by a panel of multiple CARE faculty in the field of gastroenterology, oncology, hematology and rheumatology. The CARE faculty will facilitate a speaker line up that will include clinicians, nurses, hospital pharmacists, health Canada, ethicists, medical legal, patient advocacy groups and payers to share their understanding and position regarding the integration of Biosimilars in the Canadian healthcare system.
The congress will be open to a diverse audience of multiple specialties including but not limited to hematology, oncology, gastroenterology, rheumatology, respirology, and dermatology. This audience will be comprised of physicians, patient’s groups, pharmacists, nurses, payers, members of government and sponsoring industry. 
Date: Friday, January 13th, 2017  
Time: 12:00 – 5:00 pm 
Location: Toronto Marriot Eaton Centre Hotel
Steering faculty: Dr. John Marshall (CARE Gastroenterology Faculty, McMaster University) 
Dr. John Kuruvilla (CARE Hematology Faculty, Princess Margaret Cancer Centre)               
Topics Include:
Biologic and Biosimilar Basic Science
Clinical Data Review
Health Canada Perspective
Payer Perspectives
Patient Advocacy Perspectives
aHCP Perspectives
Legal and Ethical Considerations